PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 6
- Registration Number
- NCT06327880
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants
- Conditions
- Interventions
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 343
- Registration Number
- NCT06325657
- Locations
- 🇿🇦
Synergy Biomed Research Institute, East London, Eastern CAPE, South Africa
🇿🇦Gugulethu Green Clinic, Cape Town, Western CAPE, South Africa
🇿🇦FAMCRU - Worcester, Worcester, Western CAPE, South Africa
A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- Conditions
- Interventions
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 13
- Registration Number
- NCT06321523
- Locations
- 🇰🇷
Pfizer, Seoul, Korea, Republic of
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
- Conditions
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 100
- Registration Number
- NCT06321510
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei, Taiwan
A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT06307457
- Locations
- 🇩🇰
Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 600
- Registration Number
- NCT06297161
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 260
- Registration Number
- NCT06294925
- Locations
- 🇩🇪
Praxis Heil und Müller, Andernach, Germany
🇬🇧Imperial College Healthcare NHS, London, United Kingdom
🇬🇧University College London Hospital, London, United Kingdom
A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3000
- Registration Number
- NCT06291831
- Locations
- 🇧🇭
Pfizer Gulf FZ, Busaiteen, Bahrain
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 5
- Registration Number
- NCT06285097
- Locations
- 🇯🇵
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
🇯🇵The Cancer Institute Hospital of JFCR, Koto, Tokyo, Japan
🇵🇷Hospital Oncologico Dr. Isaac Gonzalez-Martinez, Rio Piedras, Puerto Rico
A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 122
- Registration Number
- NCT06279234
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸Qps-Mra, Llc, South Miami, Florida, United States